文献速递心力衰竭与心肌病心律失常

心力衰竭合并心房颤动管理更新:聚焦导管消融

Update on management of atrial fibrillation in heart failure: a focus on ablation.
PubMed 文献 · Heart · 2021-06-04

该综述讨论心力衰竭合并心房颤动患者的治疗现状,强调缓解症状与降低血栓栓塞及心衰恶化风险。文中回顾早期率与节律控制研究、基础疾病与危险因素管理的重要性,并批判性评估已开展的导管消融研究,提出患者选择可能是优化结局的下一步方向。

要点

  • 房颤治疗目标为缓解症状并降低血栓栓塞及心衰发生或恶化风险。
  • 基础心血管疾病与危险因素管理是房颤综合治疗的重要组成部分。
  • 导管消融在无显性心衰患者中已成功应用多年,近年扩展至心衰患者。

核心结论

  • 房颤合并心衰的治疗需兼顾症状缓解、血栓栓塞风险降低及心衰发生或恶化风险控制。
  • 导管消融在无显性心衰患者中应用成功多年,近年已尝试用于心衰患者。
  • 患者选择可能是进一步优化房颤合并心衰患者结局的下一步方向。

研究设计与样本

  • 综述:讨论当前描述心力衰竭合并心房颤动治疗的文献。
  • 回顾早期率与节律控制研究、基础疾病与危险因素管理及导管消融研究。

主要发现

  • 房颤与心衰发病率近年均大幅上升。
  • 症状缓解可通过药物或非药物的率控制或节律控制,联合基础心血管疾病与危险因素的优化治疗实现。
  • 对已开展的导管消融研究结合更大规模(事后)消融研究进行批判性评估。

临床怎么用

  • 对房颤合并心衰患者应综合管理基础心血管疾病与危险因素。
  • 症状缓解可选药物或非药物的率控制或节律控制策略。
  • 导管消融可考虑用于心衰患者,但需关注患者选择以优化结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation is increasingly encountered in patients with heart failure. Both diseases have seen tremendous rises in incidence in recent years. In general, the treatment of atrial fibrillation is focused on relieving patients from atrial fibrillation-related symptoms and risk reduction for thromboembolism and the occurrence or worsening of heart failure. Symptomatic relief may be accomplished by either (non-)pharmacological rate or rhythm control in combination with optimal therapy of underlying cardiovascular morbidities and risk factors. Atrial fibrillation ablation has been performed in patients without overt heart failure successfully for many years. However, in recent years, attempts have been made for patients with heart failure as well. In this review, we discuss the current literature describing the treatment of atrial fibrillation in heart failure. We highlight the early rate versus rhythm control studies, the importance of addressing underlying conditions and treatment of risk factors. A critical evaluation will be performed of the catheter ablation studies that have been performed so far in light of larger (post-hoc) ablation studies. Furthermore, we will hypothesise the role of patient selection as next step in optimising outcome for patient with atrial fibrillation and heart failure.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Mulder BA, Rienstra M, Van Gelder IC, et al. Update on management of atrial fibrillation in heart failure: a focus on ablation. Heart. 2021. PMID: 34088767. doi:10.1136/heartjnl-2020-318081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。